Standpoint Research Upgrades Teva Pharma (TEVA) to Buy
Go back to Standpoint Research Upgrades Teva Pharma (TEVA) to Buy| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 36.57 +0.43 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.14 | 52 Week High | $66.55 | |||
| Open | $36.17 | 52 Week Low | $37.82 | |||
| Day High | $36.98 | P/E | N/A | |||
| Day Low | $36.13 | EPS | $0.00 | |||
| Volume | 3,843,620 | |||||

